M. Zimmermann

Transcriptomic similarities and differences between mouse models and human Alzheimer’s Disease

P. Rosa-Neto, M. D. De Bastiani, T. Pascoal, 2021, bioRxiv.

Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study

Jeffery A. Hall, E. Kobayashi, J. Soucy, 2022, Frontiers in Neurology.

Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases

A. Aliaga, J. Soucy, P. Vitali, 2022, Neurology.

Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease

P. Rosa-Neto, M. D. De Bastiani, T. Pascoal, 2023, bioRxiv.

In vivo hippocampal cornu ammonis 1–3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes

Jeffery A. Hall, E. Kobayashi, J. Soucy, 2021, Epilepsia.

Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease

P. Rosa-Neto, M. D. De Bastiani, T. Pascoal, 2021, bioRxiv.